Finnegan Stone
London,United Kingdom
Summary
Detail-oriented professional with expertise in market access strategies, complex data analysis and health economic modelling. Committed to leveraging problem-solving skills to drive strategic insights and enhance business outcomes. Offering a strong analytical background with solid problem-solving and critical thinking skills.
Overview
6
6
years of professional experience
2025
2025
years of post-secondary education
Work history
Analyst - Market Access and Pricing Strategy
Dolon Ltd
London
10.2024 - Current
- Contributed to team projects by providing key analytic insights on multiple projects, driving forward workstreams on several projects.
- Maintained in-depth knowledge of industry advancements and emerging software tools to improve analytical workflow.
- Gained project management experience and facilitated the delivery of workshops and the external delivery of projects.
- Contributed to business development, facilitating over £500,000 of business won within H1 2025.
Health Economics Intern
MSD
06.2024 - 09.2024
- Planned, created and executed modelling, budget impact analysis and associated literature review to evaluate the cost-effectiveness of Pembrolizumab for early-stage triple-negative breast cancer.
- Supported the preparation of regulatory documents and HTA submissions to NICE and SMC, contributing towards successful reimbursement outcomes for Pembrolizumab indication expansions.
Research Assistant
University of Cambridge
09.2021 - 08.2022
- Researched novel chemotherapeutic co-treatments.
- Carried out quantitative and qualitative data analysis researching the mRNA response to Doxorubicin and Trazodone exposure to aid projects researching Trazodone's effect in reducing cancer metastasis.
- Presented bi-weekly seminars to cultivate interest in mRNA therapeutics and their potential role in cancer treatment.
Marketing Intern
GSK
06.2019 - 07.2019
- Attended internal strategic discussions on pricing and distribution complexities of key treatment drugs within EMEA.
- Gained insight into some of the manufacturing challenges along with the clinical trial process and the hurdles involved in getting Juluca (dolutegravir and rilpivirine) to market.
Education
MSc - International Health Policy
London School of Economics and Political Science (LSE)
London, London October 2023 - 06.2024
BSc - Biochemistry (Industrial)
University of Leeds
Leeds, United KingdomSkills
- VBA programming
- Advanced excel proficiency
- Microsoft PowerPoint
- Microsoft Word
- Global data (POLI)
- STATA
- Market access strategies
- Problem-solving
- Data collection and analysis
Timeline
Analyst - Market Access and Pricing Strategy
Dolon Ltd
10.2024 - Current
Health Economics Intern
MSD
06.2024 - 09.2024
Research Assistant
University of Cambridge
09.2021 - 08.2022
Marketing Intern
GSK
06.2019 - 07.2019
MSc - International Health Policy
London School of Economics and Political Science (LSE)
October 2023 - 06.2024
BSc - Biochemistry (Industrial)
University of Leeds
Similar Profiles
MD Faruk Roshid ChyMD Faruk Roshid Chy
Director at New Dolon Chapa Sherwni Center and Event managent and car rentals.Director at New Dolon Chapa Sherwni Center and Event managent and car rentals.
Aishat Aderayo BaleAishat Aderayo Bale
Nursery Educator at ABC DAYCARENursery Educator at ABC DAYCARE
Bhavya SinghBhavya Singh
Client Advisor at Tod’sClient Advisor at Tod’s
Snehika DatlaSnehika Datla
Administrative officer at Etane LimitedAdministrative officer at Etane Limited
Amarawathi Babu KasarapuAmarawathi Babu Kasarapu
Senior Health and Social Care Worker at St Matthews HealthcareSenior Health and Social Care Worker at St Matthews Healthcare